Tirzepatide 10MG

Product Specifications

• Compound: Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
• CAS Number: 2023788-19-2
• Molecular Weight: 4813.45 g/mol
• Sequence: 39 amino acid linear peptide with C-20 fatty diacid modification
• Purity: >99%+ (HPLC verified)
• Form: Lyophilized powder
• Quantity: 10mg per vial
• Third-Party Testing: Testides Analytical (independent third-party lab)

Mechanism of Action

Tirzepatide is a synthetic 39-amino acid peptide engineered as a dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. In-vitro receptor binding assays demonstrate that tirzepatide exhibits approximately 5-fold selectivity for the GIP receptor relative to GLP-1. The peptide incorporates a C-20 fatty diacid moiety that facilitates albumin binding, extending its pharmacokinetic half-life in preclinical models.

Research Applications

Tirzepatide has been investigated across multiple preclinical research domains. In-vitro studies have demonstrated its effects on incretin signaling pathways, including cAMP accumulation in GIP and GLP-1 receptor-expressing cell lines. In animal models, research has examined its influence on pancreatic islet cell function and central metabolic signaling pathways versus single-receptor agonism.

How Tirzepatide Compares to Other Research Peptides

Tirzepatide belongs to the incretin-targeting peptide family alongside semaglutide (selective GLP-1 agonist) and retatrutide (triple GIP/GLP-1/glucagon agonist). While semaglutide activates only the GLP-1 receptor, tirzepatide dual mechanism engages both GIP and GLP-1 pathways.

Storage and Handling

Store lyophilized tirzepatide at -20C for long-term stability. Reconstituted solution should be stored at 2-8C and used within 30 days. Avoid repeated freeze-thaw cycles.

Shipping from the USA

All tirzepatide orders ship same-day from our US facility with temperature-controlled packaging. Free shipping on orders over $200.

Certificate of Analysis (COA)

Testing Laboratory: Testides Analytical. Purity (HPLC-UV): 99.88%. Report: DBAV-TIRZ-10-052926. Download Full COA (PDF)

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

About this Tirzepatide reference material

Tirzepatide is supplied by Maple Research Labs as a lyophilised powder in a sealed vial under catalogue reference TRZ-10MG. Every vial is drawn from a single production batch and is released only against a batch-specific certificate of analysis. The batch documented for this listing was tested by Testides Analytical, an independent third-party laboratory, and the report reference is shown in the specification above.

Analytical specification for this Tirzepatide batch

Identity and purity were determined by high-performance liquid chromatography with ultraviolet detection (HPLC-UV) and reported at 99.88%. The material is registered under CAS 2023788-19-2, molecular formula C225H348N48O68. HPLC-UV separates the target compound from related substances and process impurities and quantifies each as a percentage of total peak area, which is why the result is stated to two decimal places rather than as a rounded claim. Public registry data for CAS 2023788-19-2 can be checked independently via PubChem.

What a batch-specific COA means

A batch-specific certificate describes the exact material in the vial being shipped, not a representative sample from an earlier production run. Where a supplier publishes a single document covering an entire product line, that certificate cannot describe the unit received. Maple Research Labs does not publish a Tirzepatide listing without a matching batch document, and the certificate for this batch is downloadable from this page.

Handling and storage

Supplied as a lyophilised powder. Store sealed vials away from light and moisture; refrigeration extends the shelf stability of the dry powder. Allow a chilled vial to reach ambient temperature before opening, to limit condensation on the stopper. Handle in a controlled laboratory environment using appropriate personal protective equipment, and record the batch reference against your own experimental documentation.

Availability and shipping

Orders ship from the United States. Tirzepatide is listed as a single vial, so a laboratory can verify the certificate and the material against its own analytical methods before committing to a larger order.

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.

Third-party testing and traceability for Tirzepatide

Testing for Tirzepatide is commissioned from Testides Analytical, a laboratory independent of both Maple Research Labs and the manufacturer. Independent testing matters because an in-house result is produced by the party with an interest in the outcome, and a third-party result is not. Each certificate states the analytical method used, the date of analysis and the batch identifier, so a result can be traced to a specific production run rather than to a product name in general.

Laboratories sourcing Tirzepatide for method development or comparative work generally need three things on file: a purity figure produced by a stated method, a batch identifier that matches the vial in hand, and a supplier willing to publish both before purchase rather than after. Those are the terms this listing is published on, and the certificate is available without an account or an enquiry.